Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Targeting intrinsically disordered proteins in rational drug discovery.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
What place for {blacktriangledown}cannabis extract in MS?
Efferent manifestations of multiple sclerosis.
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review.
The role of Ets2 transcription factor in the induction of microRNA-155 by LPS, and its targeting by IL-10.
The treatment of neuromyelitis optica.
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.
Exploring myelin dysfunction in multiple system atrophy.
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.
Efficacy of the ANAM General Neuropsychological Screening battery (ANAM GNS) for Detecting Neurocognitive Impairment in a Mixed Clinical Sample.
[Assessment of the influence of rehabilitation in patients treated in a hospital rehabilitation ward due to consequences of neurological diseases].
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
Pages
« first
‹ previous
…
418
419
420
421
422
423
424
425
426
…
next ›
last »